The companies Daiichi Sankyo and AstraZeneca have worked together for several years.
This week’s podcast is sponsored by Daiichi Sankyo and AstraZeneca.
On this week’s podcast, we have a conversation with Markus Kosch, the head of Oncology Europe and Canada for Daiichi Sankyo, and Greg Rossi, Senior Vice President, Oncology, Europe and Canada, from AstraZeneca, who are joining forces to bring new oncology medicines into clinical practice.
In March 2019, AstraZeneca and Daiichi Sankyo entered into a global collaboration to jointly develop and commercialize health technologies worldwide. Their collaboration is designed to leverage strengths and combine efforts to improve patient care.
Partnering 2030: The Biotech Perspective 2023
Download Inpart’s latest report revealing the priorities of out-licensers worldwide.
